BioSpace News Archive

Drug Development

Xeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121)

Xeris Biopharma Holdings today announced topline results from its recently completed Phase 2 multi-center, open label, study of XP-8121 for the treatment of adults with hypothyroidism.

May 30, 2024
·
10 min read
Deals

Celcuity Announces Pricing of Underwritten Common Stock Offering

Celcuity Inc. today announced the pricing of an underwritten offering of 3,871,000 shares of its common stock at an offering price of $15.50 per share.

May 30, 2024
·
5 min read
Optellum showcases AI for precision lung cancer treatment at ASCO 2024

Optellum , a global leader in AI-driven clinical decision support for early lung cancer diagnosis, has launched its multimodal therapy AI guidance platform for life science research.

May 30, 2024
·
4 min read
BioMidwest

Pacira BioSciences to Participate in Fireside Chat at the 2024 Jefferies Global Healthcare Conference

Pacira BioSciences, Inc. announced that it will participate in an analyst-led fireside chat at the 2024 Jefferies Global Healthcare Conference at 11:00 AM ET on Thursday, June 6, 2024 in New York.

May 30, 2024
·
1 min read
Genetown

Compass Therapeutics to Participate in the Jefferies Global Healthcare Conference

Compass Therapeutics, Inc. today announced that the Company will participate in a fireside chat at the Jefferies Global Healthcare Conference taking place in New York City, NY June 5 – 6, 2024.

May 30, 2024
·
1 min read
Genetown

Prime Medicine to Present at Upcoming Investor Conferences

Prime Medicine, Inc. today announced that Keith Gottesdiener, M.D., President and Chief Executive Officer will present at two upcoming investor conferences.

May 30, 2024
·
2 min read
Bio NC

Humacyte to Present at the Jefferies Global Healthcare Conference

Humacyte, Inc. today announced that Laura Niklason, M.D., Ph.D., Founder, President, and Chief Executive Officer, will present at the Jefferies Global Healthcare Conference, in New York, NY on Thursday, June 6, 2024.

May 30, 2024
·
2 min read
Genetown

Corbus Pharmaceuticals to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

Corbus Pharmaceuticals Holdings, Inc. today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will provide a corporate update and participate in one-on-one investor meetings at the 45th Annual Goldman Sachs Global Healthcare Conference to be held June 10-13, 2024 in Miami Beach, FL.

May 30, 2024
·
3 min read
Genetown

ORYZON to Provide Corporate Progress Updates at Several Events in June

Oryzon Genomics, S.A announced today that its management will give an update on corporate progress at several international events in June.

May 30, 2024
·
8 min read
Biotech Bay

Rezolute to Participate in the Jefferies Global Healthcare Conference

Rezolute, Inc. for serious metabolic and rare diseases, today announced that Nevan Charles Elam, Chief Executive Officer and Founder of Rezolute, will participate in a fireside chat during the Jefferies Global Healthcare Conference on Thursday, June 6, 2024, at 1:00 p.m. ET in New York City.

May 30, 2024
·
1 min read